OpGen Partnering with New York State Department of Health and Merck’s ILÚM Health Solutions to Detect Antimicrobial-Resistant Infections
The DOH, ILÚM and
“We are proud to be a part of this groundbreaking initiative throughout the
The precision medicine solutions provided by
The OpGen Acuitas AMR Gene Panelu.5.47, a distributed, rapid diagnostics platform capable of detection and identification of multidrug-resistant bacterial pathogens in under three hours and for use with the Acuitas Lighthouse Software. Together, these products can rapidly identify and locate antibiotic resistance threats in healthcare institutions and networks. Both systems are commercially available for Research Use Only (RUO) and are anticipated to be submitted for FDAclearance after completion of ongoing and planned clinical trials. In future iterations, OpGen’s Acuitas technologies are anticipated to provide custom testing solutions to supplement evolving Wadsworth Laboratorytesting and New York State’s DOH surveillance needs.
- The OpGen Acuitas Lighthouse Software includes
Acuitas Lighthouseepidemiology dashboards with high-resolution pathogen tracking through healthcare facilities, to cities, regions, as well as the entire state.
- ILÚM’s technology platform, a Commercial Off The Shelf (COTS) solution which assembles and streams analyzed health data from across locations and health care systems. This data includes laboratory test results, pharmacy, orders, and ADT (admissions, discharges, transfers). The platform offers patient and program-specific data analytics and visualization capabilities to users via a web application and a mobile device application. Also, it enables case browsing, patient monitoring, detection and prioritization and performance monitoring and reporting for disease management, including actionable insights in support of quality improvement efforts, disease surveillance, pathway adherence, and ultimately impacting outcomes.
About Antimicrobial-resistant Infections
The Wadsworth Center laboratories stand at the forefront of biomedical and environmental sciences and their interplay. The Center serves a vital role in the
This press release includes statements relating to OpGen’s collaboration with
Source: OpGen, Inc.